These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 985536)

  • 21. The isomers of cocaine and tropacocaine: effect on 3H-catecholamine uptake by rat brain synaptosomes.
    Komiskey HL; Miller DD; LaPidus JB; Patil PN
    Life Sci; 1977 Oct; 21(8):1117-22. PubMed ID: 916808
    [No Abstract]   [Full Text] [Related]  

  • 22. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
    Harris JE; Baldessarini RJ
    Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
    [No Abstract]   [Full Text] [Related]  

  • 23. Nisoxetine antagonism of norepinephrine depletion in brain and heart after alpha-methyl-m-tyrosine administration.
    Fuller RW; Snoddy HD; Perry KW
    Neuropharmacology; 1979 Oct; 18(10):767-70. PubMed ID: 514460
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of dibutyryl cyclic AMP, theophylline and papaverine on the release of 3H-catecholamines from rat brain striatal and cortical synaptosomes.
    Eitan A; Hershkowitz M
    Eur J Pharmacol; 1977 Dec; 46(4):323-7. PubMed ID: 201472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.
    Ferris RM; Tang FL; Maxwell RA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of mazindol on rat brain synaptosomal monoamine uptake.
    Sugrue MF; Mireylees SE
    Biochem Pharmacol; 1978; 27(14):1843-7. PubMed ID: 708465
    [No Abstract]   [Full Text] [Related]  

  • 28. d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes.
    Raiteri M; Bertollini A; Angelini F; Levi G
    Eur J Pharmacol; 1975 Nov; 34(1):189-95. PubMed ID: 1234761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amantadine and catecholamine uptake.
    Herblin WF
    Biochem Pharmacol; 1972 Jul; 21(14):1993-5. PubMed ID: 4649347
    [No Abstract]   [Full Text] [Related]  

  • 30. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 31. The blockade of serotonin uptake into synaptosomes:relationship to an interaction with monoamine oxidase inhibitors.
    Sinclair JG; Lo GF
    Can J Physiol Pharmacol; 1977 Apr; 55(2):180-7. PubMed ID: 17455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional changes in monoamine content and uptake of the rat brain during postnatal development.
    Nomura Y; Naitoh F; Segawa T
    Brain Res; 1976 Jan; 101(2):305-15. PubMed ID: 1244975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates.
    Horn AS
    Br J Pharmacol; 1973 Feb; 47(2):332-8. PubMed ID: 4722047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of narcotic analgesic drugs on the uptake and release of neurotransmitters in isolated synaptosomes.
    Clouet DH; Williams N
    J Pharmacol Exp Ther; 1974 Feb; 188(2):419-28. PubMed ID: 4811303
    [No Abstract]   [Full Text] [Related]  

  • 35. Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors.
    Fuller RW; Snoddy HD; Molloy BB
    Psychopharmacol Commun; 1975; 1(5):455-64. PubMed ID: 1228825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An inhibitor of dopamine uptake, LR5182, cis-3-(3,4-dichlorophenyl)-2-n,n-dimethylaminomethyl-bicyclo-[2,2,2]-octane, hydrochloride.
    Wong DT; Bymaster FP
    Life Sci; 1978 Sep; 23(10):1041-7. PubMed ID: 713683
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of phencyclidine on [3H]catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain.
    Smith RC; Meltzer HY; Arora RC; Davis JM
    Biochem Pharmacol; 1977 Aug; 26(15):1435-9. PubMed ID: 901557
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.
    Raiteri M; Del Carmine R; Bertollini A; Levi G
    Eur J Pharmacol; 1977 Jan; 41(2):133-43. PubMed ID: 832672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of carbon monoxide-induced hypoxia on synaptosomal uptake and release of dopamine in rat striatum.
    Chai KJ; Bae SK
    Yonsei Med J; 1988; 29(2):129-38. PubMed ID: 3218256
    [No Abstract]   [Full Text] [Related]  

  • 40. Amphetamine's locomotor-stimulant and noreprinephrine-releasing effects: evidence for selective antagonism by nisoxetine.
    Tyler TD; Tessel RE
    Psychopharmacology (Berl); 1979 Sep; 64(3):291-6. PubMed ID: 41278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.